Core Viewpoint - Tianan Health (00383.HK) reported a total revenue of HKD 783 million for the six months ending June 30, 2025, representing a year-on-year decrease of approximately 4.67% [1] - The profit attributable to shareholders was HKD 11.979 million, a decline of about 44.69% compared to the previous year [1] - Basic earnings per share were HKD 0.0111, down from HKD 0.0199 in the first half of 2024 [1] Revenue and Profit Analysis - The decrease in revenue was primarily due to a reduction in operating income from the medical segment [1] - The company experienced an increase in non-cash fair value losses on investment properties [1] - However, this decline was partially offset by a reduction in employee benefit expenses, recognition of unrealized foreign exchange gains, and a decrease in income tax expenses [1]